![](https://medschool.umich.edu/sites/default/files/styles/square_1_1/public/2023-12/Aday-Jacob2023.jpg?h=f10f7809&itok=moLijUON)
Available to mentor
![](https://medschool.umich.edu/sites/default/files/styles/square_1_1/public/2023-12/Aday-Jacob2023.jpg?h=f10f7809&itok=moLijUON)
Jacob S. Aday, Ph.D. is a Research Investigator in the Department of Anesthesiology, with appointments in the Chronic Pain and Fatigue Research Center (CPFRC) as well as the Michigan Psychedelic Center (M-PsyC). He completed his undergraduate and master's degrees in Psychology at Northern Michigan University, where he worked in Dr. Adam Prus’s Neuropsychopharmacology Lab and Dr. Joshua Carlson’s Cognitive Affective Behavior and Integrative Neuroscience (CABIN) Lab. During his doctoral training, Jake was mentored by Drs. Christopher Davoli and Emily Bloesch at Central Michigan University, where they established a productive program of research centered on the emerging field of ‘psychedelic science’. During this time, he was also recruited by Drug Science, the leading independent scientific body on drugs in the UK, to be an honorary research assistant and study under Professor David Nutt. Jake then joined the Translational Psychedelic Research Program (TrPR) at the University of California, San Francisco (UCSF) as a postdoctoral researcher in 2021. There, he was mentored by Dr. Joshua Woolley on how to design, implement, and interpret complex psychedelic clinical trials. As a Research Investigator in the Department of Anesthesiology, Dr. Aday is interested in the cognitive and social effects of psychedelics, improving research methodology and safety with the drugs, and examining the potential applications of psychedelic therapy for chronic pain.
-
PhDCentral Michigan University, Mount Pleasant, MI, 2021
-
MSNorthern Michigan University, Marquette, MI, 2017
-
BSNorthern Michigan University, Marquette, MI, 2015
• Psychedelics
• Social Cognition
• Emotion
• Chronic Pain
-
Aday J, Mason NL, Wood BJ, Kramer HM, Ortiz CE, Vest MF, Sagrera C, Healy CJ. Psychedelic Medicine, 2024 Feb;Journal ArticlePsychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the Field
DOI:10.1089/psymed.2023.0053 -
Aday JS, Bloesch EK, Davis AK, Domoff SE, Scherr K, Woolley JD, Davoli CC. J Psychoactive Drugs, 2024 Feb 4; 1 - 10.Journal ArticleEffects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study.
DOI:10.1080/02791072.2024.2312980 PMID: 38310541 -
Aday J, Bloesch EK, Davis AK, Domoff SE, Scherr K, Woolley JD, Davoli CC. Journal of Humanistic Psychology, 2024Journal ArticleIncreases in Aesthetic Experience Following Ayahuasca Use: A Prospective, Naturalistic Study
DOI:10.1177/00221678241230609 -
Glynos NG, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P. Front Psychiatry, 2024 15: 1349565Journal ArticlePsychedelic substitution: altered substance use patterns following psychedelic use in a global survey.
DOI:10.3389/fpsyt.2024.1349565 PMID: 38455520 -
Aday J, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley E, Rosen R, Woolley J. PsyArXiv,PreprintPsychedelic-assisted psychotherapy: Where is the psychotherapy research?
DOI:10.31234/osf.io/s3yjd -
Aday J. 2023 Nov;PresentationChallenges in Trial Design for Psychedelic-Assisted Therapies
-
Aday JS, Barnett BS, Grossman D, Murnane KS, Nichols CD, Hendricks PS. Psychedelic Medicine, 2023 Sep 1; 1 (3): 150 - 165.Journal ArticlePsychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
DOI:10.1089/psymed.2023.0013 -
Aday J. 2023 Sep;PresentationPsychedelic science: An overview of contemporary directions